Chemotherapy before surgery for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a combination of chemotherapy drugs given before surgery to shrink advanced stomach cancer tumors and improve outcomes. It may help patients with stage T3/4 or node-positive stomach cancer who have not had prior treatment for their cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with stomach (gastric) adenocarcinoma that is locally advanced (T3-4, N+ or M0).
- You have not had previous chemotherapy, radiation, or surgery for your stomach cancer, aside from early-stage removal (endoscopic resection).
- You are generally healthy and able to perform daily activities (ECOG score 0-1).
- You have adequate organ function (kidneys, liver, blood) and no serious uncontrolled illnesses.
- You are willing to sign an informed consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This study tests whether a specialized surgery called HIPEC (heat-treated chemotherapy placed in the belly) can improve outcomes for people with advanced stomach cancer that has reached the lining of the abdomen. It’s given after you’ve already had standard chemotherapy, aiming to better control disease in the belly.
This trial tests a treatment called HIPEC (heated chemotherapy given directly into the abdomen during surgery) for stomach cancer that has spread to the lining of the belly. The goal is to see if this approach can help remove or shrink the cancer and improve outcomes.
This Phase 3 trial studies whether adding a heated chemotherapy procedure during surgery (HIPEC) before the main cancer treatment can lower the chance that stomach cancer returns in the belly. It is for people with advanced stomach cancer who are at higher risk of cancer coming back in the peritoneum (the lining of the abdomen).
This trial compares two chemotherapy combinations given before surgery for stomach cancer that has not spread. The goal is to see which treatment works better and to shrink the tumor before removal.
This trial combines heated chemotherapy directly into the abdomen (HIPEC) with standard chemotherapy and an immunotherapy drug to treat advanced stomach cancer that has spread to the lining of the abdomen. The goal is to see if this combination can shrink tumors and help patients live longer.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.